InVivo Therapeutics Holdings Corp (OTCQB:NVIV)

1.60
Data as of Apr 17
 +0.02 / +1.27%
Today’s Change
0.94
Today|||52-Week Range
6.20
-30.31%
Year-to-Date
SECTOR
Industrial Services
INDUSTRY
Engineering & Construction
MARKET CAP
$125.6M

Company Description

Invivo Therapeutics Holdings Corp. is a medical device company, which develops and commercializes groundbreaking technologies for the treatment of spinal cord injuries. Its platform technologies focus on minimizing tissue damage sustained following acute injury and promoting neural plasticity of the spared healthy tissue, which may result in full or partial functional recovery. The company intends to leverage its primary platform technology to develop and commercialize three products: a biocompatible polymer scaffolding device to treat acute spinal cord injuries; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute spinal cord injuries and a biocompatible polymer scaffolding device seeded with autologous human neural stem cells to treat acute and chronic spinal cord injuries. Its additional applications of platform technologies include the potential treatment for, spinal cord injury following tumor removal, peripheral nerve damage, and postsurgical treatment of any transected nerve. The company was founded by Joseph P. Vacanti, Frank M. Reynolds and Robert Langer on November 28, 2005 and is headquartered in Cambridge, MA.

Contact Information

Invivo Therapeutics Holdings Corp.
One Kendall Square
Cambridge Massachusetts 02142
P:(617) 863-5500
Investor Relations:

Employees

Shareholders

Individual stakeholders24.22%
Mutual fund holders1.71%
Other institutional0.17%

Top Executives

Mark D. PerrinChief Executive Officer & Director
Steven F. McAllisterChief Financial Officer
Brian HessChief Science Officer
Louis VaickusChief Medical Officer
Thomas R. UlichChief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.